October 2010

Regression of Cutaneous Warts in a Patient With WILD Syndrome Following Recombinant Quadrivalent Human Papillomavirus Vaccination

Author Affiliations

Author Affiliations: Department of Dermatology, Venereology, and Allergology, Ruhr-University Bochum, Bochum, Germany (Dr Kreuter); Infection and Cancer Program, German Cancer Research Center (DKFZ), Heidelberg, Germany (Dr Waterboer); and Institute of Virology, National Reference Center for Papilloma and Polyomaviruses, University of Cologne, Cologne, Germany (Dr Wieland).


Copyright 2010 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2010

Arch Dermatol. 2010;146(10):1196-1197. doi:10.1001/archdermatol.2010.290

In the May 2010 issue of the Archives, Venugopal and Murrell1 described a 31-year-old man who showed rapid clearance of cutaneous warts after having received 3 doses of a recombinant quadrivalent human papillomavirus (HPV) vaccination. We herein describe a severely immunosuppressed woman who experienced a similarly substantial regression of widespread cutaneous warts following vaccination with a quadrivalent HPV-6, -11, -16, and -18 vaccine.

First Page Preview View Large
First page PDF preview
First page PDF preview